Letters, Testimony & Comments

BIO submits letters, testimony, and comments to government and regulatory bodies throughout the United States and around the world.

Featured Letters, Testimony, & Comments

CSBA Letter to Congressional Leaders on PBM, PPRV…

Dear Congressional Leaders:On behalf of the Council of State Bioscience Associations (CSBA)—a national coalition of independent, state and territory-based organizations representing the full breadth of America’s biotechnology ecosystem—we write to…

Learn more

BIO's Comments on Advisory Committee on…

Re: Docket No. CDC-2025-0783; Advisory Committee on Immunization Practices (ACIP) MeetingDear Dr. Zadeh and Members of the ACIP:The Biotechnology Innovation Organization (BIO) appreciates the opportunity to provide comments to the Advisory Committee…

Learn more

Testimony of BIO President & CEO John F. Crowley…

Chairman Cassidy, Ranking Member Sanders, and distinguished Members of the Committee:Thank you for the opportunity to appear before you today on behalf of the Biotechnology Innovation Organization (BIO), which represents more than 1,000…

Learn more

A Consumer Tool Kit Explaining Livestock Cloning - Points for Retailers to Provide to Consumers

March 10, 2016

Cloning is an assisted reproductive technique that produces an animal that is an identical twin of an existing animal.

BIO Statement: BIO Urges FDA Release of Risk Assessment on Animal Cloning

March 10, 2016

Letter to the dairy industry urging support for the U.S. Food and Drug Administration's release of the final risk assessment on animal cloning.

Cloning Recommendation before the National Organic Standards Board

March 10, 2016

Livestock clones and their progeny can be raised in accordance with the Organic Foods Production Act (OFPA), specifically 7 USC §6502 Definitions, §6504 National standards for organic production, and §6509 Animal production practices and materials.

China's Compliance with WTO Commitments

March 10, 2016

Comments concerning China's compliance with WTO commitments.

Federal Register Notice of 2010 TIP Competition: NIST issues notice of 2010 TIP competition

March 10, 2016

NIST includes biomanufacturing as an area of "critical national need" for 2010 TIP competition.

Amendment to Federal Register Notice: NIST issues amendments 2010 TIP competition

March 10, 2016

NIST clarifies that device development is not a focus of 2010 TIP competition.

Vaccines: 2009-H1N1 Influenza NVAC Vaccination Program Financing

March 10, 2016

This Report contains NVAC recommendations based on the Working Group’s findings and conclusions, and includes recommendations developed by the NVAC Adolescent Working Group. It takes into account public comments and extensive stakeholder input…

Promoting Health and Preventing Disease: Childhood and Adult Vaccine Updates and Recommendations

March 10, 2016

Centers for Disease Control & Prevention, Clinician Outreach and Community Activity (COCA) Conference Call July 27, 2010.

Vaccines: 2008 Draft Strategic National Vaccine Plan

March 10, 2016

The National Vaccine Program was established in 1986 to achieve optimal prevention of infectious diseases through immunization and optimal prevention of adverse reactions to vaccines.

Biodefense: 2009 National Strategy for Countering Biological Threats

March 10, 2016

White House National Security Council - November 2009 National Strategy for Countering Biological Threats